子代SARS-CoV-2阳性率与母婴传播时间:动态系统综述与Meta分析
该动态系统综述与Meta分析纳入472项研究(206项队列研究、266项病例系列和病例报告;28952名母亲、18237名婴儿),评估SARS-CoV-2感染母亲所生婴儿的阳性率、母婴传播时间及围产结局。结果显示,14271名婴儿中经RT-PCR检测阳性率为1.8%(95%CI 1.2%至2.5%),592名阳性婴儿中14例确认母婴传播。母亲重症covid-19等与子代阳性相关。
要点
- SARS-CoV-2感染母亲所生婴儿RT-PCR阳性率为1.8%(95%CI 1.2%至2.5%)。
- 592名阳性婴儿中14例确认母婴传播:宫内7例、产时2例、产后早期5例。
- 母亲重症covid-19、死亡、ICU入住及产后感染与子代SARS-CoV-2阳性相关。
核心结论
- SARS-CoV-2感染母亲所生婴儿的SARS-CoV-2阳性率较低,证据提示存在确认的垂直传播但可能罕见,母亲covid-19严重程度似乎与子代SARS-CoV-2阳性相关。
研究设计与样本
- 动态系统综述与Meta分析,检索2019年12月1日至2021年8月3日主要数据库,纳入因任何原因就医并确诊SARS-CoV-2感染的孕妇和近期孕妇(包括流产或流产后)的队列研究,以及评估阳性婴儿母婴传播时间和可能性的病例系列和病例报告。
- 共纳入472项研究(206项队列研究、266项病例系列和病例报告;28952名母亲、18237名婴儿),采用随机效应模型合并率,关联以比值比和95%置信区间报告。
- 采用世界卫生组织分类对母婴传播时间进行归类(宫内、产时、产后早期)。
主要发现
- 14271名SARS-CoV-2感染母亲所生婴儿中,1.8%(95%CI 1.2%至2.5%;140项研究)经逆转录聚合酶链反应(RT-PCR)检测阳性。
- 592名有暴露时间及检测类型和时间数据的SARS-CoV-2阳性婴儿中,14例确认母婴传播:宫内7例(评估448例)、产时2例(评估18例)、产后早期5例(评估70例)。
- 800名有结局数据的SARS-CoV-2阳性婴儿中,20例死产、23例新生儿死亡、8例早期妊娠丢失,749名婴儿随访结束时存活。
- 母亲重症covid-19(OR 2.4,95%CI 1.3至4.4)、母亲死亡(OR 14.1,95%CI 4.1至48.0)、母亲入住重症监护室(OR 3.5,95%CI 1.7至6.9)及母亲产后感染(OR 5.0,95%CI 1.2至20.1)与子代SARS-CoV-2阳性相关。
- RT-PCR阳性率存在地区差异,北美研究为0.1%(95%CI 0.0%至0.3%),拉丁美洲和加勒比地区研究为5.7%(95%CI 3.2%至8.7%)。
关键数值与推荐
- SARS-CoV-2感染母亲所生婴儿RT-PCR阳性率:1.8%(95%CI 1.2%至2.5%;140项研究;14271名婴儿)。
- 确认母婴传播14例:宫内7例(评估448例)、产时2例(评估18例)、产后早期5例(评估70例)。
- 母亲重症covid-19与子代阳性相关:OR 2.4(95%CI 1.3至4.4)。
- 母亲死亡与子代阳性相关:OR 14.1(95%CI 4.1至48.0)。
- 母亲入住ICU与子代阳性相关:OR 3.5(95%CI 1.7至6.9);母亲产后感染与子代阳性相关:OR 5.0(95%CI 1.2至20.1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring. DESIGN: Living systematic review and meta-analysis. DATA SOURCES: Major databases between 1 December 2019 and 3 August 2021. STUDY SELECTION: Cohort studies of pregnant and recently pregnant women (including after abortion or miscarriage) who sought hospital care for any reason and had a diagnosis of SARS-CoV-2 infection, and also provided data on offspring SARS-CoV-2 status and risk factors for positivity. Case series and case reports were also included to assess the timing and likelihood of mother-to-child transmission in SARS-CoV-2 positive babies. DATA EXTRACTION: Two reviewers independently extracted data and assessed study quality. A random effects model was used to synthesise data for rates, with associations reported using odds ratios and 95% confidence intervals. Narrative syntheses were performed when meta-analysis was inappropriate. The World Health Organization classification was used to categorise the timing of mother-to-child transmission (in utero, intrapartum, early postnatal). RESULTS: 472 studies (206 cohort studies, 266 case series and case reports; 28 952 mothers, 18 237 babies) were included. Overall, 1.8% (95% confidence interval 1.2% to 2.5%; 140 studies) of the 14 271 babies born to mothers with SARS-CoV-2 infection tested positive for the virus with reverse transcriptase polymerase chain reaction (RT-PCR). Of the 592 SARS-CoV-2 positive babies with data on the timing of exposure and type and timing of tests, 14 had confirmed mother-to-child transmission: seven in utero (448 assessed), two intrapartum (18 assessed), and five during the early postnatal period (70 assessed). Of the 800 SARS-CoV-2 positive babies with outcome data, 20 were stillbirths, 23 were neonatal deaths, and eight were early pregnancy losses; 749 babies were alive at the end of follow-up. Severe maternal covid-19 (odds ratio 2.4, 95% confidence interval 1.3 to 4.4), maternal death (14.1, 4.1 to 48.0), maternal admission to an intensive care unit (3.5, 1.7 to 6.9), and maternal postnatal infection (5.0, 1.2 to 20.1) were associated with SARS-CoV-2 positivity in offspring. Positivity rates using RT-PCR varied between regions, ranging from 0.1% (95% confidence interval 0.0% to 0.3%) in studies from North America to 5.7% (3.2% to 8.7%) in studies from Latin America and the Caribbean. CONCLUSION: SARS-CoV-2 positivity rates were found to be low in babies born to mothers with SARS-CoV-2 infection. Evidence suggests confirmed vertical transmission of SARS-CoV-2, although this is likely to be rare. Severity of maternal covid-19 appears to be associated with SARS-CoV-2 positivity in offspring. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020178076. READERS' NOTE: This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication.
引用
- Allotey J, Chatterjee S, Kew T, et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ. 2022. PMID: 35296519. doi:10.1136/bmj-2021-067696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。